Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3606 | 1257 | 36.3 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
441 | 3 | TRAIL//SURVIVIN//APOPTOSIS | 26474 |
3606 | 2 | TRIPTOLIDE//CELASTROL//PDCD5 | 1257 |
11572 | 1 | TRIPTOLIDE//CELASTROL//TRIPTERYGIUM WILFORDII HOOK F | 970 |
31019 | 1 | PDCD5//PROGRAMMED CELL DEATH 5//PROGRAMMED CELL DEATH 5 PDCD5 | 159 |
33210 | 1 | PARAPTOSIS//BAP31//AIP1 ALIX | 128 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TRIPTOLIDE | authKW | 7104515 | 29% | 80% | 364 |
2 | CELASTROL | authKW | 1863526 | 10% | 63% | 122 |
3 | PDCD5 | authKW | 732096 | 3% | 84% | 36 |
4 | TRIPTERYGIUM WILFORDII HOOK F | authKW | 702661 | 4% | 64% | 45 |
5 | TRIPTERYGIUM WILFORDII | authKW | 597053 | 4% | 47% | 52 |
6 | PARAPTOSIS | authKW | 378277 | 2% | 54% | 29 |
7 | PROGRAMMED CELL DEATH 5 | authKW | 297557 | 1% | 88% | 14 |
8 | TRIPTERYGIUM | authKW | 226703 | 1% | 67% | 14 |
9 | TRIPTONIDE | authKW | 202419 | 1% | 83% | 10 |
10 | 5R 5 HYDROXYTRIPTOLIDE | authKW | 196752 | 1% | 90% | 9 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Integrative & Complementary Medicine | 2104 | 5% | 0% | 64 |
2 | Pharmacology & Pharmacy | 1645 | 23% | 0% | 287 |
3 | Oncology | 1027 | 16% | 0% | 207 |
4 | Chemistry, Medicinal | 615 | 7% | 0% | 91 |
5 | Cell Biology | 421 | 11% | 0% | 141 |
6 | Biochemistry & Molecular Biology | 323 | 17% | 0% | 219 |
7 | Medicine, Research & Experimental | 295 | 7% | 0% | 86 |
8 | Toxicology | 199 | 5% | 0% | 57 |
9 | Immunology | 174 | 7% | 0% | 94 |
10 | Rheumatology | 165 | 2% | 0% | 30 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HEMORHEOL | 179905 | 2% | 37% | 20 |
2 | HUMAN DIS GENOM | 87184 | 2% | 13% | 27 |
3 | SINO FRENCH COOPERAT CENT | 75904 | 0% | 63% | 5 |
4 | BASIC TRANSLAT | 65140 | 1% | 21% | 13 |
5 | JIANGSU DRUG SCREENING | 60286 | 2% | 11% | 23 |
6 | BINHU HOSP HEFEI CITY | 48581 | 0% | 100% | 2 |
7 | SHANGHAI TCM | 48581 | 0% | 100% | 2 |
8 | SINOFRENCH COOPERAT CENT | 48581 | 0% | 100% | 2 |
9 | STATE DRUG CHEM | 48581 | 0% | 100% | 2 |
10 | JIANGSU PROV PHARMACODYNAM EVALUAT | 32386 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ACTA PHARMACOLOGICA SINICA | 2873 | 2% | 0% | 26 |
2 | CLINICAL HEMORHEOLOGY AND MICROCIRCULATION | 2604 | 1% | 1% | 14 |
3 | INTERNATIONAL IMMUNOPHARMACOLOGY | 2446 | 2% | 0% | 21 |
4 | PEZCOLLER FOUNDATION SYMPOSIA | 1712 | 1% | 1% | 12 |
5 | JOURNAL OF TRADITIONAL CHINESE MEDICINE | 1157 | 0% | 1% | 6 |
6 | MOLECULAR MEDICINE REPORTS | 1124 | 1% | 0% | 17 |
7 | CHINESE JOURNAL OF CANCER RESEARCH | 930 | 0% | 1% | 5 |
8 | JOURNAL OF ETHNOPHARMACOLOGY | 844 | 2% | 0% | 19 |
9 | CANCER LETTERS | 770 | 2% | 0% | 20 |
10 | CELL STRESS & CHAPERONES | 761 | 0% | 1% | 6 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TRIPTOLIDE | 7104515 | 29% | 80% | 364 | Search TRIPTOLIDE | Search TRIPTOLIDE |
2 | CELASTROL | 1863526 | 10% | 63% | 122 | Search CELASTROL | Search CELASTROL |
3 | PDCD5 | 732096 | 3% | 84% | 36 | Search PDCD5 | Search PDCD5 |
4 | TRIPTERYGIUM WILFORDII HOOK F | 702661 | 4% | 64% | 45 | Search TRIPTERYGIUM+WILFORDII+HOOK+F | Search TRIPTERYGIUM+WILFORDII+HOOK+F |
5 | TRIPTERYGIUM WILFORDII | 597053 | 4% | 47% | 52 | Search TRIPTERYGIUM+WILFORDII | Search TRIPTERYGIUM+WILFORDII |
6 | PARAPTOSIS | 378277 | 2% | 54% | 29 | Search PARAPTOSIS | Search PARAPTOSIS |
7 | PROGRAMMED CELL DEATH 5 | 297557 | 1% | 88% | 14 | Search PROGRAMMED+CELL+DEATH+5 | Search PROGRAMMED+CELL+DEATH+5 |
8 | TRIPTERYGIUM | 226703 | 1% | 67% | 14 | Search TRIPTERYGIUM | Search TRIPTERYGIUM |
9 | TRIPTONIDE | 202419 | 1% | 83% | 10 | Search TRIPTONIDE | Search TRIPTONIDE |
10 | 5R 5 HYDROXYTRIPTOLIDE | 196752 | 1% | 90% | 9 | Search 5R+5+HYDROXYTRIPTOLIDE | Search 5R+5+HYDROXYTRIPTOLIDE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZHOU, ZL , YANG, YX , DING, J , LI, YC , MIAO, ZH , (2012) TRIPTOLIDE: STRUCTURAL MODIFICATIONS, STRUCTURE-ACTIVITY RELATIONSHIPS, BIOACTIVITIES, CLINICAL DEVELOPMENT AND MECHANISMS.NATURAL PRODUCT REPORTS. VOL. 29. ISSUE 4. P. 457 -475 | 112 | 93% | 73 |
2 | LI, XJY , JIANG, ZZ , ZHANG, LY , (2014) TRIPTOLIDE: PROGRESS ON RESEARCH IN PHARMACODYNAMICS AND TOXICOLOGY.JOURNAL OF ETHNOPHARMACOLOGY. VOL. 155. ISSUE 1. P. 67 -79 | 97 | 83% | 42 |
3 | LIU, QY , (2011) TRIPTOLIDE AND ITS EXPANDING MULTIPLE PHARMACOLOGICAL FUNCTIONS.INTERNATIONAL IMMUNOPHARMACOLOGY. VOL. 11. ISSUE 3. P. 377 -383 | 73 | 92% | 123 |
4 | LIU, Z , MA, L , ZHOU, GB , (2011) THE MAIN ANTICANCER BULLETS OF THE CHINESE MEDICINAL HERB, THUNDER GOD VINE.MOLECULES. VOL. 16. ISSUE 6. P. 5283 -5297 | 75 | 89% | 45 |
5 | LI, G , MA, DL , CHEN, YY , (2016) CELLULAR FUNCTIONS OF PROGRAMMED CELL DEATH 5.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. VOL. 1863. ISSUE 4. P. 572 -580 | 63 | 69% | 1 |
6 | HAN, R , ROSTAMI-YAZDI, M , GERDES, S , MROWIETZ, U , (2012) TRIPTOLIDE IN THE TREATMENT OF PSORIASIS AND OTHER IMMUNE-MEDIATED INFLAMMATORY DISEASES.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 74. ISSUE 3. P. 424 -436 | 47 | 89% | 32 |
7 | TANG, W , ZUO, JP , (2012) IMMUNOSUPPRESSANT DISCOVERY FROM TRIPTERYGIUM WILFORDII HOOK F: THE NOVEL TRIPTOLIDE ANALOG (5R)-5-HYDROXYTRIPTOLIDE (LLDT-8).ACTA PHARMACOLOGICA SINICA. VOL. 33. ISSUE 9. P. 1112-1118 | 50 | 85% | 12 |
8 | WONG, KF , YUAN, Y , LUK, JM , (2012) TRIPTERYGIUM WILFORDII BIOACTIVE COMPOUNDS AS ANTICANCER AND ANTI-INFLAMMATORY AGENTS.CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. VOL. 39. ISSUE 3. P. 311-320 | 56 | 65% | 45 |
9 | BAO, J , DAI, SM , (2011) A CHINESE HERB TRIPTERYGIUM WILFORDII HOOK F IN THE TREATMENT OF RHEUMATOID ARTHRITIS: MECHANISM, EFFICACY, AND SAFETY.RHEUMATOLOGY INTERNATIONAL. VOL. 31. ISSUE 9. P. 1123 -1129 | 41 | 95% | 35 |
10 | ZHENG, Y , ZHANG, WJ , WANG, XM , (2013) TRIPTOLIDE WITH POTENTIAL MEDICINAL VALUE FOR DISEASES OF THE CENTRAL NERVOUS SYSTEM.CNS NEUROSCIENCE & THERAPEUTICS. VOL. 19. ISSUE 2. P. 76-82 | 45 | 74% | 20 |
Classes with closest relation at Level 2 |